The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain

This study has been completed.
Sponsor:
Collaborator:
Allergan
Information provided by:
Palo Alto Veterans Institute for Research
ClinicalTrials.gov Identifier:
NCT00282958
First received: January 25, 2006
Last updated: March 4, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given